OR5H5P

Across TCGA pan-cancer cohorts, OR5H5P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated OR5H5P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher OR5H5P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR5H5P expression acts as an unfavorable survival marker.

MESO, LGG, and KIRC are the cancer types where OR5H5P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.281	0.594	<.001	126	view →
LGG	DFS	Tertile	All	0.171	0.741	<.001	45	view →
KIRC	DFS	Tertile	III,IV	0.127	0.749	.004	36	view →
LIHC	OS	Tertile	All	0.168	0.786	<.001	36	view →
TGCT	OS	Tertile	All	0.771	0.968	.012	18	view →
KIRP	OS	Tertile	All	0.118	0.688	.007	18	view →
BLCA	OS	Tertile	IV	0.297	0.596	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

OR5H5P–MESO (OS)

Open the MESO breakdown →